[ ProofPilot raises $1.85 million in seed funding ]
ProofPilot , which graduated from Blueprint Health’s accelerator earlier this year, has raised $1.85 million to help make clinical trial design and management for biotech and medical device companies run smoother.
Founded in 2013, ProofPilot is a startup that helps researchers design and manage scientific studies.
The company raised the capital to further develop its technology.
|City||New York, New York|
|Founder / CEO||Matthew Amsden|
|Investors||Brooklyn Bridge Ventures|
|Cue Ball LLC|